The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.18
Bid: 15.06
Ask: 15.14
Change: 0.24 (1.61%)
Spread: 0.08 (0.531%)
Open: 15.50
High: 15.50
Low: 14.66
Prev. Close: 14.94
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EnQuest PLC proposes to offer senior notes

26 Mar 2014 07:02

RNS Number : 1902D
EnQuest PLC
26 March 2014
 



 

 

 

EnQuest PLC (ENQ)

 

EnQuest PLC proposes to offer senior notes

 

London, March 2014 - EnQuest PLC ("EnQuest" or the "Company") today announces that it intends to offer $500 million in aggregate principal amount of senior unsecured notes due 2022 (the "Notes"). The Notes, the net proceeds of which will be used for general corporate purposes, will be senior obligations of the Company and will rank pari passu with all present and future senior unsecured indebtedness of the Company. The guarantees of the Notes by certain subsidiaries of the Company will be subordinated to the obligations of the Guarantors under the Company's senior secured revolving credit facility.

 

* * *

 

This announcement does not constitute an offer to sell or the solicitation of an offer to buy the Notes or any other security and shall not constitute an offer, solicitation or sale in the United States or in any jurisdiction in which, or to any persons to whom, such offering, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any jurisdiction.

The Notes and the related guarantees have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

 

This announcement may include projections and other "forward-looking" statements within the meaning of applicable securities laws. Any such projections or statements reflect the current views of the Company about future events and financial performance. The use of any of the words "expect," "anticipate," "continue," "will," "project," "should," "believe," "plans," "intends" and similar expressions are intended to identify forward-looking information or statements. Although the Company believes that the expectations and assumptions on which such forward-looking statements and information are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Company can give no assurance that such statements and information will prove to be correct. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties.

 

The forward-looking statements and information contained in this announcement are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

 

Within the United Kingdom, this announcement is directed only at persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 ("relevant persons"). The investment or investment activity to which this announcement relates is only available to and will only be engaged in with relevant persons and person who receive this announcement who are not relevant persons should not rely or act upon it.

 

This press release shall not be considered an "offer of securities to the public" for purposes of the Luxembourg law on prospectus for public offering dated 10 July 2005 or give rise to or require the publication of a prospectus in any EU member state which has implemented Directive 2003/71/EC (together with any applicable implementing measures, including Directive 2010/73/EC, in any member state).

 

Ends

 

 

 

For further information please contact:

 

EnQuest PLC

Tel: +44 (0)20 7925 4900

Amjad Bseisu (Chief Executive)

Jonathan Swinney (Chief Financial Officer)

Michael Waring (Head of Communications & Investor Relations)

 

Tulchan Communications

Tel: +44 (0)20 7353 4200

Martin Robinson

David Allchurch

Martin Pengelley

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSESEEIFLSEFD
Date   Source Headline
3rd Dec 20192:32 pmRNSTotal Voting Rights
2nd Dec 20199:22 amRNSDirector/PDMR Shareholding
27th Nov 20198:40 amRNSDirector/PDMR Shareholding
21st Nov 20197:00 amRNSOperations update
28th Oct 201910:33 amRNSDirector/PDMR Shareholding
21st Oct 201910:11 amRNSDirector/PDMR Shareholding
18th Oct 201910:25 amRNSTotal Voting Rights
11th Oct 201912:13 pmRNSDirector/PDMR Shareholding
9th Oct 20194:27 pmRNSDirector/PDMR Shareholding
2nd Oct 20191:08 pmRNSDirector/PDMR Shareholding
17th Sep 201911:25 amRNSHolding(s) in Company
16th Sep 201911:13 amRNSDirector/PDMR Shareholding
9th Sep 201911:44 amRNSDirector/PDMR Shareholding
5th Sep 20197:00 amRNSChairman Succession
5th Sep 20197:00 amRNSResults for the six months ended 30 June 2019
2nd Sep 201912:04 pmRNSHolding(s) in Company
28th Aug 20193:22 pmRNSTotal Voting Rights
29th Jul 20199:27 amRNSTotal Voting Rights
17th Jul 201911:30 amRNSDirector/PDMR Shareholding
12th Jul 20193:00 pmRNSDirector/PDMR Shareholding
9th Jul 20199:15 amRNSDirector/PDMR Shareholding
1st Jul 20192:48 pmRNSDirector/PDMR Shareholding
27th Jun 20192:24 pmRNSReport on Payments to Govts
26th Jun 201911:54 amRNSTotal Voting Rights
25th Jun 20193:46 pmRNSDirector/PDMR Shareholding
18th Jun 201911:30 amRNSDirector/PDMR Shareholding
10th Jun 20192:33 pmRNSDirector/PDMR Shareholding
5th Jun 20194:12 pmRNSDirector/PDMR Shareholding
3rd Jun 201912:08 pmRNSDirector/PDMR Shareholding
30th May 20198:30 amRNSBlock Listing Application
28th May 20194:28 pmRNSDirector/PDMR Shareholding
23rd May 20194:54 pmRNSAGM Statement
23rd May 20197:00 amRNSOperations Update
20th May 20193:10 pmRNSDirector/PDMR Shareholding
13th May 20194:15 pmRNSDirector/PDMR Shareholding
8th May 201912:50 pmRNSDirector/PDMR Shareholding
26th Apr 20194:34 pmRNSDirector/PDMR Shareholding
17th Apr 20194:00 pmRNSNotice of AGM and Report & Accounts
8th Apr 201910:20 amRNSDirector/PDMR Shareholding
1st Apr 201911:36 amRNSDirector/PDMR Shareholding
27th Mar 20192:35 pmRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNSFinal Results
15th Mar 20197:00 amRNSBoard Appointment
12th Mar 20197:11 amRNSKraken 2P Reserves
5th Feb 20197:00 amRNSOperations update
30th Jan 20193:22 pmRNSBoard Committee Membership
28th Jan 201911:31 amRNSChange of Directors' Details
23rd Jan 201910:08 amRNSHolding(s) in Company
18th Jan 20194:09 pmRNSDirector/PDMR Shareholding
17th Dec 201812:22 pmRNSChange of Director's Details

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.